Home » Authors » James Etheridge

Articles by James Etheridge

Immutep Closes EUR2.5M Round For Therapeutic Vaccine Development

April 21, 2004

By James Etheridge

Ablynx Completes EUR25M Series B Financing For Nanobody Platform

April 9, 2004

By James Etheridge

Ablynx Completes EUR25M Series B Financing For Nanobody Platform

April 9, 2004

By James Etheridge

Ablynx Completes EUR25M Series B Financing For Nanobody Platform

April 7, 2004

By James Etheridge

Ablynx Completes EUR25M Series B Financing For Nanobody Platform

April 7, 2004

By James Etheridge

Innogenetics Gains Therapeutic Vaccine Program From Genencor

March 31, 2004

By James Etheridge

Innogenetics Gains Vaccine Program From Genencor

March 31, 2004

By James Etheridge

Innogenetics Gains Therapeutic Vaccine Program From Genencor

March 31, 2004

By James Etheridge

Innogenetics Gains Vaccine Program From Genencor

March 31, 2004

By James Etheridge

CareX Raises EUR25M in Second Round To Fund Development

March 10, 2004

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 13, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 13, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Keros stock wilts as it halts two dosing arms in hypertension study
BioWorld
After Keros Therapeutics Inc.’s voluntary halt of dosing in two arms of its phase II study in pulmonary arterial hypertension, the company’s stock crumpled after...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.